Abstract:Recent evidence suggests that the metastatic spread of head and neck squamous cell carcinomas (HNSCC) requires the function of cancer stem cells endowed with multipotency, self-renewal, and high tumorigenic potential. We demonstrated that cancer stem cells reside in perivascular niches and are characterized by high aldehyde dehydrogenase (ALDH) activity and high CD44 expression (ALDHhighCD44high) in HNSCC. Here, we hypothesize that endothelial cell-secreted interleukin-6 (IL-6) contributes to tumor progression by enhancing the migratory phenotype and survival of cancer stem cells. Analysis of tissue microarrays generated from the invasive fronts of 77 HNSCC patients followed-up for up to 11 years revealed that high expression of IL-6 receptor (IL-6R) (p=0.0217) or co-receptor gp130 (p=0.0422) correlates with low HNSCC patient survival. We observed that endothelial cell-secreted factors induce epithelial to mesenchymal transition (EMT) and enhance invasive capacity of HNSCC cancer stem cells. Conditioned medium from CRISPR/Cas9-mediated IL-6 knockout primary human endothelial cells is less chemotactic for cancer stem cells in a microfluidics-based system than medium from control endothelial cells (p<0.05). Blockade of the IL-6 pathway with a humanized anti-IL-6R antibody (tocilizumab) inhibited endothelial cell-induced motility in vitro and decreased the fraction of cancer stem cells in vivo. Notably, xenograft HNSCC tumors vascularized with IL-6-knockout endothelial cells exhibited slower tumor growth and smaller cancer stem cell fraction. These findings demonstrate that endothelial cell-secreted IL-6 enhances the motility and survival of highly tumorigenic cancer stem cells, suggesting that endothelial cells can create a chemotactic gradient that enables the movement of carcinoma cells towards blood vessels.

Crosstalk Between Tumor and Endothelial Cells Promotes Tumor Angiogenesis by MAPK Activation of Notch Signaling

Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype Through a Soluble Form of Jagged-1

Jagged1-Notch1-deployed Tumor Perivascular Niche Promotes Breast Cancer Stem Cell Phenotype Through Zeb1.

Notch Signaling Regulates Vessel Structure and Function Via Hspg2.

Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective

Adrenergic signaling promotes angiogenesis through endothelial cell-tumor cell crosstalk.

Endothelial Cords Promote Tumor Initial Growth prior to Vascular Function through a Paracrine Mechanism

Lymphotoxin‐α Promotes Tumor Angiogenesis in HNSCC by Modulating Glycolysis in a PFKFB3‐dependent Manner

Notch Mediates Inter-tissue Communication to Promote Tumorigenesis

Notch Signaling Pathway and Tumor Angiogenesis

Interplay Between Notch 1 and Notch 3 Promotes EMT and Tumor Initiation in Squamous Cell Carcinoma

Tumor-derived Jagged1 promotes cancer progression through immune evasion

Endothelial-derived interleukin-6 induces cancer stem cell motility by generating a chemotactic gradient towards blood vessels

NNMT switches the proangiogenic phenotype of cancer-associated fibroblasts via epigenetically regulating ETS2/VEGFA axis

Inhibition of JAK2/STAT3 Reduces Tumor‐induced Angiogenesis and Myeloid‐derived Suppressor Cells in Head and Neck Cancer

Epidermal Growth Factor Receptor Inhibition Reduces Angiogenesis Via Hypoxia-Inducible Factor-1α and Notch1 in Head Neck Squamous Cell Carcinoma

Angiocrine Factors Deployed by Tumor Vascular Niche Induce B Cell Lymphoma Invasiveness and Chemoresistance

Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma

NCK1 Promotes the Angiogenesis of Cervical Squamous Carcinoma Via Rac1/PAK1/MMP2 Signal Pathway

Notch1 Promotes Glioma Cell Migration and Invasion by Stimulating Β‐catenin and NF‐κB Signaling Via AKT Activation

Endothelial cell Notch signaling programs cancer-associated fibroblasts to promote tumor immune evasion